A team of Australian researchers apply extrusion-based three-dimensional cellular bioprinting to deliver rapid and high-throughput generation of kidney organoids with highly reproducible cell number and viability. Automated extrusion-based bioprinting for kidney organoid production delivers improvements in throughput, quality control, scale and structure, facilitating in vitro and in vivo applications of stem cell-derived human kidney tissue.

reference:

Lawlor KT, Vanslambrouck JM, Higgins W et al. Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation. Nat. Mater. doi: 10.1038/s41563-020-00853-9 (Epub ahead of print) (2020);

https://www.3dmednet.com/mini-kidneys-bioprinted-for-toxicology-research-and-treatment-developments/